Economic implications of resistance to antimalarial drugs

PharmacoEconomics

Volumn 10, Issue 3, 1996, Pages 225-238

  Phillips, Margaret ^a   Phillips Howard, Penelope A ^b,c  

^a Centers for Dis Contr and Prev ^*

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISIN; CHLOROQUINE; DAPSONE; DOXYCYCLINE; HALOFANTRINE; MEFLOQUINE; MINOCYCLINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUINIDINE; QUININE; SULFADOXINE; SULFALENE; TETRACYCLINE;

CLINICAL TRIAL; DRUG RESISTANCE; ECONOMIC ASPECT; HUMAN; MALARIA; PRIORITY JOURNAL; REVIEW;

EID: 0029784883     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199610030-00004     Document Type: Review

References (45)

1. WHO. World malaria situation in 1992. Weekly Epidemiological Record 1994; 42: 309-14
2. WHO. World malaria situation in 1992. Weekly Epidemiological Record 1994; 43: 317-21
3. WHO. World malaria situation in 1992. Weekly Epidemiological Record 1994; 44: 325-30
4. Brinkmann U, Brinkmann A. Malaria and health in Africa: the present situation and epidemiological trends. Trop Med Parasitol 1991; 42: 204-13
5. Greenberg AE, Ntumbanzondo M, Ntula N, et al. Hospital-based surveillance of malaria-related pediatric morbidity and mortality in Kinshasa, Zaire. Bull World Health Organ 1989; 67: 189-96
6. Greenwood BM, Bradley AK, Greenwood AM. Mortality and morbidity from malaria among children in a rural area of the Gambia, West Africa. Trans Royal Society Trop Med Hyg 1987; 81: 478-86
7. Brabin BJ. The risks and severity of malaria in pregnancy. Applied Field Research in Malaria Report No. 1: UNDP/World Bank/WHO TDR; Geneva, 1991
8. Nur ETM. The impact of malaria on labour use and efficiency in the Sudan. Soc Sci Med 1993; 37 (9): 1115-9
9. Mills A. Is malaria control a priority? Evidence from Nepal. Health Econ 1993; 2: 333-47
10. WHO. The implementation of the global strategy for malaria control. Technical Report Series, No. 839, Geneva, 1993
11. WHO. Practical chemotherapy of malaria: report of a WHO scientific group. Technical Report Series, No. 805, Geneva, 1990
12. WHO. Advances in malaria chemotherapy. Technical Report Series 711, Geneva, 1984
13. WHO. Chemotherapy of malaria and resistance to antimalarials. Technical Report Series No. 529, Geneva, 1973
14. WHO. Antimalarial drug policies: data requirements, treatment of uncomplicated malaria and management of malaria in pregnancy: report of an informal consultation. Geneva: 1994 Mar. WHO/MAL/94.1070
15. Bloland PB, Lackritz EM, Kazembe PM, et al. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 1993; 167: 932-7
16. Nosten F, ter Kuile FO, Chongsuphajaisiddi T, et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 1991; 337: 1140-3
17. Hein TT, White NJ. Qinghaosu. Lancet 1993; 341: 603-8
18. WHO. The role of artemisinin and its derivatives in the current treatment of malaria (1994-1995). Geneva: 1994. WHO/MAL/ 94.1067
19. Foster SD. Pricing distribution and use of antimalarial drugs. Bull World Health Organ 1991; 69: 349-63
20. Shapira A, Beales P, Holloran M. Malaria: living with drug resistance. Parasitol Today 1993; 9 (5): 168-73
21. Ettling M, Shepard D. Economic cost of malaria in Rwanda. Trop Med Parasitol 1991; 42: 214-8
22. Kaewsonthi S, Harding A. Cost and performance of malaria surveillance: the patients perspective. Southeast Asian J Trop Med Public Health 1986; 17: 406-12
23. Ettling M, Thimasarn K, Shepard D, et al. Economic analysis of several types of malaria clinics in Thailand. Bull World Health Organ 1991; 69 (4): 467-76
24. Sauerborn R, Shepard D, Ettling U, et al. Estimating the direct and indirect economic costs of malaria in a rural district of Burkina Faso. Trop Med Parasitol 1991; 42: 219-23
25. Sudre P, Breman J, McFarland D, et al. Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. Int J Epidemiol 1992; 21 (1): 146-54
26. Sudre P, Breman JG, Koplan JP. Malaria mortality and drug resistance in Africa: results of a Delphi survey [letter]. Lancet 1990; I: 722
27. Kengeya-Kayondo J. Rural women's recognition of malaria, their treatment seeking behaviour and how the latter is influenced by perception of cause. Geneva; WHO, 1993. S20/181/ SER/73
28. Carme B, Koulengana P, Nzambi A, et al. Current practices for the prevention und treatment of malaria in children and pregnant women in the Brazzaville Region (Congo). Ann Trop Med Parasitol 1992; 86: 319-22
29. Makubalo EL. Malaria and chloroquine use in northern Zambia [thesis]. University of London, 1991
30. Deming MS, Gayibor A, Murphy K, et al. Home treatment of febrile children with antimalarial drugs in Togo. Bull World Health Organ 1989; 67: 695-700
31. Breman JC, Campbell CC. Combatting severe malaria in African children. Bull World Health Organ 1988; 66: 611-20
32. Slutsker L, Chitsulo L, Macheso A, et al. Treatment of malaria episodes among children in Malawi: results of a KAP survey. Trop Med Parasitol 1994; 45: 61-4
33. Ejezie GC, Ezedinachi EN, Emeribe AO. Malaria and its treatment in rural villages of Aboh Mbaise, Imo State, Nigeria. Acta Tropica 1991; 48: 17-24
34. Redd SC, Bloland PB, Kazembe PN, et al. Usefulness of clinical case-definitions in guiding therapy for African children with malaria or pneumonia. Lancet 1992; II: 1140-3
35. Bloland P, Redd S, Kazembe PM, et al. Co-trimoxazole for childhood febrile illness in malaria-endemic regions. Lancet 1991; 337: 518-520
36. Armstrong Schellenberg JRM, Smith T, Alonso PL, et al. What is clinical malaria? Finding case definitions for field research in highly endemic areas. Parasitol Today 1994; 10: 439-42
37. Najera JA, Liese BH, Hammer J. Malaria: new patterns and perspectives. 1992. World Bank Technical Paper No. 183
38. Bassett MT, Taylor P, Bvirakare J, et al. Clinical diagnosis of malaria: can we improve? J Trop Med Hyg 1991; 94: 65-9
39. Jonkman A, Chibwe R, Khoromana C, et al. Cost-saving through microscopy-based versus presumptive diagnosis of malaria in adult outpatients in Malawi. Bull World Health Organ 1995; 73 (2): 223-7
40. Gomes M, Salazar NP. Chemotherapy principles in practice - a case study of the Philippines. Soc Sci Med 1990; 30: 789-96
41. Beadle C, Long GW, Weiss WR, et al. Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay. Lancet 1994; 343: 564-8
42. World Bank. World Development Report Oxford: Oxford University Press, 1993
43. Special Programme for Research and Training in Tropical Diseases. Tropical Diseases Research: Twenty years of progress Twelfth Programme Report. Geneva: WHO, 1995
44. Foster S. Economic prospects for a new antimalarial drug. Trans Royal Society Trop Med Hyg 1994; 88 Suppl. 1: 55-6
45. Mnyika KS, Killewo JZJ. Irrational drug use in Tanzania. Health Pol Plan 1991; 6: 180-84